Trials / Completed
CompletedNCT01012531
Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen
Efficacy and Safety of Subcutaneous Cluster Immunotherapy With Cluster-allergoid CLUSTOID Grasses/Rye (Glutaraldehyde-polymerized Allergen Extract of Mixtures of Grass and Rye Allergens) in Patients With Allergic Rhinoconjunctivitis Sensitized to Grass and With or Without Rye Pollen Sensitization
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- Roxall Medizin · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the efficacy and safety of cluster immunotherapy with highly polymerized allergen extracts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Subcutaneous injections with highly polymerized allergen extract | cluster schedule |
| BIOLOGICAL | Subcutaneous injection with placebo | cluster schedule |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-11-01
- Completion
- 2009-12-01
- First posted
- 2009-11-13
- Last updated
- 2011-07-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01012531. Inclusion in this directory is not an endorsement.